Regulation of Hematopoietic Stem Cells
Role of Hematopoietic Growth Factors
Regulation of Angiogenesis and Blood Supply
Immunoglobulin-like Cell Adhesion Molecules
Paracrine Signaling
Paracrine Signaling
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 6, 2026

Automated Quantification of Hematopoietic Cell – Stromal Cell Interactions in Histological Images of Undecalcified Bone
Published on: April 8, 2015
Takako Negishi-Koga1, Hiroshi Takayanagi
1Department of Cell Signaling, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University , Tokyo, Japan . ; Japan Science and Technology Agency, ERATO, Takayanagi Osteonetwork Project , Tokyo, Japan . ; Global Center of Excellence Program, International Research Center for Molecular Science in Tooth and Bone Diseases, Tokyo Medical and Dental University , Tokyo, Japan .
Bone tissue is constantly renewed through a process involving osteoclasts and osteoblasts. Recent research shows that Semaphorins, a type of signaling protein, play a role in regulating this process. Semaphorin 4D, from osteoclasts, inhibits bone formation, while Semaphorin 3A, from osteoblasts, protects bone by reducing resorption and increasing formation. These findings suggest that Semaphorins act as communication factors between bone cells. The study highlights the complexity of bone remodeling and proposes a new classification for these regulatory proteins.
09:28Assaying the Ability of Diffusible Signaling Molecules to Reorient Embryonic Spinal Commissural Axons
Published on: March 8, 2010
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Area of Science:
Background:
Bone homeostasis relies on precise coordination between resorption and formation. Classical coupling factors have been identified as key players in this process. However, recent findings suggest that additional regulatory mechanisms may exist. These mechanisms involve molecules that modulate communication between bone cell types. Prior research has shown that osteoclasts release factors that stimulate bone formation. Yet, the role of other signaling molecules remains less understood. This gap motivated investigations into non-classical regulators of bone remodeling. That uncertainty drove the need to explore novel factors like Semaphorins. No prior work had resolved the full scope of cell-cell communication in bone.
Purpose Of The Study:
The study aimed to investigate the role of Semaphorins in bone cell communication. It focused on how these proteins influence coupling between resorption and formation. The researchers sought to determine if Semaphorins act as regulatory factors in bone remodeling. They examined whether these molecules could disrupt or enhance coupling processes. The motivation stemmed from observations that Semaphorins are expressed in bone cells. These proteins are known to mediate cell-cell interactions in other tissues. The study aimed to clarify their function in the skeletal system. Understanding these mechanisms could refine models of bone homeostasis.
Main Methods:
The researchers analyzed Semaphorin expression in osteoclasts and osteoblasts. They used molecular biology techniques to detect Semaphorin 4D and 3A. Cell culture experiments were conducted to assess the effects of these proteins. In vitro models allowed for controlled observation of bone cell interactions. The team measured changes in bone formation and resorption rates. They employed gene expression profiling to identify relevant signaling pathways. Functional assays evaluated the impact of Semaphorin inhibition. These methods enabled a detailed analysis of Semaphorin roles in bone remodeling.
Main Results:
Semaphorin 4D was found to inhibit bone formation when expressed by osteoclasts. This finding suggests a mechanism by which coupling is disrupted. Semaphorin 3A, produced by osteoblasts, was shown to suppress resorption. It also increased bone formation, indicating a protective effect. The study demonstrated that these Semaphorins act as bone cell communication factors. Their presence altered the balance between resorption and formation. The results provided evidence of distinct regulatory roles for each Semaphorin. These findings highlight the complexity of bone remodeling regulation.
Conclusions:
The authors propose that Semaphorins function as bone cell communication factors. These proteins modulate interactions between osteoclasts and osteoblasts. The findings suggest that Semaphorins can both enhance and disrupt coupling. The study clarifies that classical coupling factors are not the only regulators. The results support the idea that multiple mechanisms control bone homeostasis. The authors emphasize the importance of understanding these factors. They suggest that this knowledge could improve therapeutic approaches. The paper concludes that Semaphorins are essential for maintaining bone balance.
Semaphorin 4D, produced by osteoclasts, inhibits bone formation, suggesting it disrupts the coupling between resorption and formation.
Semaphorin 3A, expressed by osteoblasts, suppresses bone resorption and promotes bone formation, offering an osteoprotective effect.
Semaphorins regulate cell-cell communication in bone remodeling, providing insight into mechanisms beyond classical coupling factors.
The study used in vitro cell culture models and gene expression analysis to evaluate Semaphorin effects on bone cell interactions.
Coupling factors ensure resorption is followed by formation, maintaining skeletal homeostasis through coordinated cell activity.
The authors suggest calling Semaphorins 'bone cell communication factors' due to their role in regulating cell interactions during remodeling.